Adaptation of group A Streptococcus to human amniotic fluid

PLoS ONE

Volumn 5, Issue 3, 2010, Pages

  Sitkiewicz, Izabela ^a,b,d   Green, Nicole M ^a,b   Guo, Nina ^a,b   Bongiovanni, Ann M ^c   Witkin, Steven S ^c   Musser, James M ^a,b,c  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; BACTERIAL RNA; CARBOHYDRATE; VIRULENCE FACTOR;

AMNION FLUID; ARTICLE; CHEMISTRY; DNA MICROARRAY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; MICROBIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; STREPTOCOCCUS PYOGENES;

ADHESINS, BACTERIAL; AMNIOTIC FLUID; CARBOHYDRATES; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RNA, BACTERIAL; STREPTOCOCCUS PYOGENES; VIRULENCE FACTORS;

EID: 79952118043     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009785     Document Type: Article

References (52)

1. Cunningham MW (2000) Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13: 470-511.
2. Carapetis JR, Steer AC, Mulholland EK, Weber M (2005) The global burden of group A streptococcal diseases. Lancet Infect Dis 5: 685-694.
3. Pasteur L (1879) Septicemie puerperale. Bulletin de l'Academie de Medecine 8: 271-274.
4. Chuang I, Van BC, Beall B, Schuchat A (2002) Population-based surveillance for postpartum invasive group A Streptococcus infections, 1995-2000. Clin Infect Dis 35: 665-670.
5. Green NM, Zhang S, Porcella SF, Nagiec MJ, Barbian KD, et al. (2005) Genome sequence of a serotype M28 strain of group A Streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity. J Infect Dis 192: 760-770.
6. Green NM, Beres SB, Graviss EA, Allison JE, McGeer AJ, et al. (2005) Genetic diversity among type emm28 group A Streptococcus strains causing invasive infections and pharyngitis. J Clin Microbiol 43: 4083-4091.
7. Tettelin H, Masignani V, Cieslewicz MJ, Donati C, Medini D, et al. (2005) Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial ''pan-genome''. Proc Natl Acad Sci U S A 102: 13950-13955.
8. Mylvaganam H, Bruun T, Vindenes HA, Langeland N, Skrede S (2009) Molecular epidemiological investigation of an outbreak of invasive betahaemolytic streptococcal infection in western Norway. Clin Microbiol Infect 15: 245-252.
9. Pinho MD, Melo-Cristino J, Ramirez M (2006) Clonal relationships between invasive and noninvasive Lancefield group C and G streptococci and emmspecific differences in invasiveness. J Clin Microbiol 44: 841-846.
10. Graham MR, Virtaneva K, Porcella SF, Barry WT, Gowen BB, et al. (2005) Group A Streptococcus transcriptome dynamics during growth in human blood reveals bacterial adaptive and survival strategies. Am J Pathol 166: 455-465.
11. Shelburne SA, III, Sumby P, Sitkiewicz I, Granville C, DeLeo FR, et al. (2005) Central role of a bacterial two-component gene regulatory system of previously unknown function in pathogen persistence in human saliva. Proc Natl Acad Sci U S A 102: 16037-16042.
12. Voyich JM, Sturdevant DE, Braughton KR, Kobayashi SD, Lei B, et al. (2003) Genome-wide protective response used by group A Streptococcus to evade destruction by human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A 100: 1996-2001.
13. Goldmann O, von Kockritz-Blickwede M, Holtje C, Chhatwal GS, Geffers R, et al. (2007) Transcriptome analysis of murine macrophages in response to infection with Streptococcus pyogenes reveals an unusual activation program. Infect Immun 75: 4148-4157.
14. Eidelman AI, Nevet A, Rudensky B, Rabinowitz R, Hammerman C, et al. (2002) The effect of meconium staining of amniotic fluid on the growth of Escherichia coli and group B Streptococcus. J Perinatol 22: 467-471.
15. Pommerenke WT, Taylor PW (1953) Antibacterial properties of vaginal and cervical secretions and amniotic fluid. Ann Ostet Ginecol 75: 891-899.
16. Sumby P, Porcella SF, Madrigal AG, Barbian KD, Virtaneva K, et al. (2005) Evolutionary origin and emergence of a highly successful clone of serotype M1 group A Streptococcus involved multiple horizontal gene transfer events. J Infect Dis 192: 771-782.
17. Sitkiewicz I, Musser JM (2006) Expression microarray and mouse virulence analysis of four conserved two-component gene regulatory systems in group A Streptococcus. Infect Immun 74: 1339-1351.
18. Shelburne SA, III, Keith D, Horstmann N, Sumby P, Davenport MT, et al. (2008) A direct link between carbohydrate utilization and virulence in the major human pathogen group A Streptococcus. Proc Natl Acad Sci U S A 105: 1698-1703.
19. Sitkiewicz I, Green NM, Guo N, Bongiovanni AM, Witkin SS, et al. (2009) Transcriptome adaptation of group B Streptococcus to growth in human amniotic fluid. PLoS One 4: e6114.
20. Sozanskii A (1961) The biochemical composition of amniotic fluid and of maternal and fetal blood at various periods of pregnancy. Biull Eksp Biol Med 51: 323-326.
21. Nilsson S, Ramstrom M, Palmblad M, Axelsson O, Bergquist J (2004) Explorative study of the protein composition of amniotic fluid by liquid chromatography electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry. J Proteome Res 3: 884-889.
22. Modena AB, Fieni S (2004) Amniotic fluid dynamics. Acta Biomed 75 Suppl 1: 11-13.
23. Beck A, Bergner-Rabinowitz S, Ofek I (1969) Effect of pH on in vitro phagocytosis of Streptococcus pyogenes. J Bacteriol 100: 1204-1207.
24. Galask RP, Snyder IS (1970) Antimicrobial factors in amniotic fluid. Am J Obstet Gynecol 106: 59-65.
25. Larsen B, Snyder IS, Galask RP (1974) Bacterial growth inhibition by amniotic fluid. I. In vitro evidence for bacterial growth-inhibiting activity. Am J Obstet Gynecol 119: 492-496.
26. Larsen B, Snyder IS, Galask RP (1974) Bacterial growth inhibition by amniotic fluid. 2. Reversal of amniotic fluid bacterial growth inhibition by addition of a chemically defined medium. Am J Obstet Gynecol 119: 497-501.
27. Evans HE, Levy E, Glass L (1977) Effect of amniotic fluid on bacterial growth. Obstet Gynecol 49: 35-37.
28. Ahn YJ, Park SK, Oh JW, Sun HY, Shin SH (2004) Bacterial growth in amniotic fluid is dependent on the iron-availability and the activity of bacterial iron-uptake system. J Korean Med Sci 19: 333-340.
29. Tran SH, Caughey AB, Musci TJ (2003) Meconium-stained amniotic fluid is associated with puerperal infections. Am J Obstet Gynecol 189: 746-750.
30. Purushothaman SS, Park HS, Cleary PP (2004) Promotion of fibronectin independent invasion by C5a peptidase into epithelial cells in group A Streptococcus. Indian J Med Res 119 Suppl: 44-47.
31. Stalhammar-Carlemalm M, Areschoug T, Larsson C, Lindahl G (1999) The R28 protein of Streptococcus pyogenes is related to several group B streptococcal surface proteins, confers protective immunity and promotes binding to human epithelial cells. Mol Microbiol 33: 208-219.
32. Nair S, Poyart C, Beretti JL, Veiga-Fernandes H, Berche P, et al. (2003) Role of the Streptococcus agalactiae ClpP serine protease in heat-induced stress defence and growth arrest. Microbiology 149: 407-417.
33. Robertson GT, Ng WL, Foley J, Gilmour R, Winkler ME (2002) Global transcriptional analysis of clpP mutations of type 2 Streptococcus pneumoniae and their effects on physiology and virulence. J Bacteriol 184: 3508-3520.
34. Giard JC, Rince A, Capiaux H, Auffray Y, Hartke A (2000) Inactivation of the stress-and starvation-inducible gls24 operon has a pleiotrophic effect on cell morphology, stress sensitivity, and gene expression in Enterococcus faecalis. J Bacteriol 182: 4512-4520.
35. Malke H, Steiner K, McShan WM, Ferretti JJ (2006) Linking the nutritional status of Streptococcus pyogenes to alteration of transcriptional gene expression: the action of CodY and RelA. Int J Med Microbiol 296: 259-275.
36. Kreikemeyer B, Beckert S, Braun-Kiewnick A, Podbielski A (2002) Group A streptococcal RofA-type global regulators exhibit a strain-specific genomic presence and regulation pattern. Microbiology 148: 1501-1511.
37. Beres SB, Richter EW, Nagiec MJ, Sumby P, Porcella SF, et al. (2006) Molecular genetic anatomy of inter-and intraserotype variation in the human bacterial pathogen group A Streptococcus. Proc Natl Acad Sci U S A 103: 7059-7064.
38. Olsen RJ, Sitkiewicz I, Ayeras AA, Gonulal VE, Cantu C, et al. (2010) Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis. Proc Natl Acad Sci U S A 107: 888-893.
39. Kreikemeyer B, Boyle MD, Buttaro BA, Heinemann M, Podbielski A (2001) Group A streptococcal growth phase-associated virulence factor regulation by a novel operon (Fas) with homologies to two-component-type regulators requires a small RNA molecule. Mol Microbiol 39: 392-406.
40. Steiner K, Malke H (2002) Dual control of streptokinase and streptolysin S production by the covRS and fasCAX two-component regulators in Streptococcus dysgalactiae subsp. equisimilis. Infect Immun 70: 3627-3636.
41. Shelburne SA, III, Keith DB, Davenport MT, Horstmann N, Brennan RG, et al. (2008) Molecular characterization of group A Streptococcus maltodextrin catabolism and its role in pharyngitis. Mol Microbiol 69: 436-452.
42. Loughman JA, Caparon MG (2006) A novel adaptation of aldolase regulates virulence in Streptococcus pyogenes. EMBO J 25: 5414-5422.
43. Pierce WA, White AG (1955) Arginine and glucose metabolism in a strain of Streptococcus pyogenes. J Bacteriol 69: 230-231.
44. Degnan BA, Fontaine MC, Doebereiner AH, Lee JJ, Mastroeni P, et al. (2000) Characterization of an isogenic mutant of Streptococcus pyogenes Manfredo lacking the ability to make streptococcal acid glycoprotein. Infect Immun 68: 2441-2448.
45. Quivey RG, Kuhnert WL, Hahn K (2001) Genetics of acid adaptation in oral streptococci. Crit Rev Oral Biol Med 12: 301-314.
46. Degnan BA, Palmer JM, Robson T, Jones CE, Fischer M, et al. (1998) Inhibition of human peripheral blood mononuclear cell proliferation by Streptococcus pyogenes cell extract is associated with arginine deiminase activity. Infect Immun 66: 3050-3058.
47. Lei B, Mackie S, Lukomski S, Musser JM (2000) Identification and immunogenicity of group A Streptococcus culture supernatant proteins. Infect Immun 68: 6807-6818.
48. Samant S, Lee H, Ghassemi M, Chen J, Cook JL, et al. (2008) Nucleotide biosynthesis is critical for growth of bacteria in human blood. PLoS Pathog 4: e37.
49. van de Rijn I, Kessler RE (1980) Growth characteristics of group A streptococci in a new chemically defined medium. Infect Immun 27: 444-448.
50. Pettersson J, Schrumpf ME, Raffel SJ, Porcella SF, Guyard C, et al. (2007) Purine salvage pathways among Borrelia species. Infect Immun 75: 3877-3884.
51. Mereghetti L, Sitkiewicz I, Green NM, Musser JM (2008) Extensive adaptive changes occur in the transcriptome of Streptococcus agalactiae (group B Streptococcus) in response to incubation with human blood. PLoS One 3: e3143.
52. Mereghetti L, Sitkiewicz I, Green NM, Musser JM (2008) Remodeling of the Streptococcus agalactiae transcriptome in response to growth temperature. PLoS One 3: e2785.